{"result": {"id": "chatcmpl-BAdm9ixL2EJj9m8vu6AM4cMku0hQn", "choices": [{"finish_reason": "length", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>VEMO<|>COMPANY<|>Vemo operated in the Finance and Insurance sector from 2015 to 2021, focusing on income-share agreements. They raised an estimated $20M but failed due to competition from Lambda School and regulatory challenges. The takeaway is that ISAs need traction.<|>)\n##\n(\"entity\"<|>VENMO GROUPS<|>COMPANY<|>Venmo Groups was a company in the Finance and Insurance sector from 2015 to 2020, offering a group payments feature. It was funded by Venmo and did not raise additional funds. The company lost to Splitwise and niche competitors, highlighting that niche payments need use.<|>)\n##\n(\"entity\"<|>VITTANA<|>COMPANY<|>Vittana operated in the Finance and Insurance sector from 2008 to 2015, providing student microloans. They raised an estimated $5M but failed due to competition from Sofi and low scale. The takeaway is that microloans need reach.<|>)\n##\n(\"entity\"<|>WEALTHFRONT CASH<|>COMPANY<|>Wealthfront Cash was a company in the Finance and Insurance sector from 2018 to 2023, offering high-yield savings. It was funded by Wealthfront and did not raise additional funds. The company lost to Ally and pivoted, indicating that savings need an edge.<|>)\n##\n(\"entity\"<|>WEALTHSIMPLE TRADE<|>COMPANY<|>Wealthsimple Trade operated in the Finance and Insurance sector from 2017 to 2023, providing commission-free trading. It was funded by Wealthsimple and did not raise additional funds. The company lost to Robinhood and pivoted, showing that trading needs volume.<|>)\n##\n(\"entity\"<|>WEPAY<|>COMPANY<|>Wepay was a company in the Finance and Insurance sector from 2008 to 2020, focusing on payment processing. They raised $75M but lost to Stripe and were sold. The takeaway is that payments need scale.<|>)\n##\n(\"entity\"<|>WESABE<|>COMPANY<|>Wesabe operated in the Finance and Insurance sector from 2006 to 2011, offering a personal finance app. They raised $4M but lost to Mint and the early market, highlighting that timing matters.<|>)\n##\n(\"entity\"<|>WISE<|>COMPANY<|>Wise was a company in the Finance and Insurance sector from 2011 to 2023, specializing in international transfers. They raised $689M but lost to PayPal and high costs, indicating that transfers need an edge.<|>)\n##\n(\"entity\"<|>YAYPAY<|>COMPANY<|>YayPay operated in the Finance and Insurance sector from 2015 to 2021, focusing on accounts receivable automation. They raised $15M but lost to Bill.com and were sold, showing that automation needs scale.<|>)\n##\n(\"entity\"<|>YCHARTS<|>COMPANY<|>Ycharts was a company in the Finance and Insurance sector from 2009 to 2021, providing a financial data platform. They raised $15M but lost to Bloomberg and were sold, indicating that data needs dominance.<|>)\n##\n(\"entity\"<|>ZESTFINANCE<|>COMPANY<|>ZestFinance operated in the Finance and Insurance sector from 2009 to 2020, focusing on AI underwriting loans. They raised $112M but lost to Upstart and regulatory challenges, showing that lending needs compliance.<|>)\n##\n(\"entity\"<|>AIRA HEALTH<|>COMPANY<|>Aira Health was a company in the Health Care sector from 2015 to 2019, offering a personalized asthma/allergy app. They raised $12M but failed due to a small user base and cash shortage, indicating that niche apps need big audiences.<|>)\n##\n(\"entity\"<|>AMINO<|>COMPANY<|>Amino operated in the Health Care sector from 2013 to 2021, providing doctor search and cost estimation services. They raised $45M but lost to Zocdoc/GoodRx and slow adoption, showing that narrow focus beats broad.<|>)\n##\n(\"entity\"<|>ARIVALE<|>COMPANY<|>Arivale was a company in the Health Care sector from 2015 to 2019, offering personalized health coaching. They raised $50M but failed due to high costs and low demand, indicating that premium needs mass market.<|>)\n##\n(\"entity\"<|>AUGMEDIX<|>COMPANY<|>Augmedix operated in the Health Care sector from 2012 to 2024, providing remote medical scribes. They raised $150M but lost to software rivals and were acquired, showing that flexibility beats rigidity.<|>)\n##\n(\"entity\"<|>AVIZIA<|>COMPANY<|>Avizia was a company in the Health Care sector from 2014 to 2018, offering telemedicine for hospitals. They raised $32M but were outpaced by bigger rivals and acquired, indicating that niche needs a moat.<|>)\n##\n(\"entity\"<|>BABYLON HEALTH<|>COMPANY<|>Babylon Health operated in the Health Care sector from 2013 to 2023, providing AI-powered telemedicine. They raised $635M but failed due to overexpansion and losses, showing that quality must match scale.<|>)\n##\n(\"entity\"<|>BASIS<|>COMPANY<|>Basis was a company in the Health Care sector from 2014 to 2016, offering a health smartwatch. They raised $30M but failed due to overheating and competition, indicating that reliability is make-or-break.<|>)\n##\n(\"entity\"<|>BETTER<|>COMPANY<|>Better operated in the Health Care sector from 2016 to 2023, focusing on mental health for employees. They raised $4.5M but failed due to a crowded market and no differentiation, showing that unique value is critical.<|>)\n##\n(\"entity\"<|>BETTERHELP<|>COMPANY<|>BetterHelp was a company in the Health Care sector from 2013 to 2017, offering online therapy (early). They raised $31M but failed due to trust issues and competition, indicating that trust comes first.<|>)\n##\n(\"entity\"<|>BIOBEATS<|>COMPANY<|>BioBeats operated in the Health Care sector from 2014 to 2020, providing a stress monitoring wearable. They raised $7M but lost to bigger players and were acquired, showing that a standout use case is needed.<|>)\n##\n(\"entity\"<|>CALL9<|>COMPANY<|>Call9 was a company in the Health Care sector from 2015 to 2019, offering telemedicine for nursing homes. They raised $34M but failed due to slow growth and high costs, indicating that execution must scale.<|>)\n##\n(\"entity\"<|>CARDIOGRAM<|>COMPANY<|>Cardiogram operated in the Health Care sector from 2016 to 2021, providing a heart rate analysis app. They raised $2M but failed due to monetization and differentiation woes, showing that validation is key.<|>)\n##\n(\"entity\"<|>CARESYNC<|>COMPANY<|>CareSync was a company in the Health Care sector from 2011 to 2018, offering a care coordination platform. They raised $48M but failed due to no payer contracts and revenue, indicating that payer buy-in is needed.<|>)\n##\n(\"entity\"<|>CAREZONE<|>COMPANY<|>CareZone operated in the Health Care sector from 2013 to 2020, providing a medication management app. They raised $161M but lost to free tools and were sold, showing that defensible revenue matters.<|>)\n##\n(\"entity\"<|>CLARITYN<|>COMPANY<|>Clarityn was a company in the Health Care sector from 2016 to 2020, offering AI eye diagnostics. They raised $20M but lost to IDx and faced regulatory delays, indicating that regulatory wins are key.<|>)\n##\n(\"entity\"<|>CLINKLE<|>COMPANY<|>Clinkle operated in the Health Care sector from 2011 to 2016, providing a mobile wallet (health-adjacent). They raised $30M but failed due to leadership issues and no product, showing that execution over promises is crucial.<|>)\n##\n(\"entity\"<|>CUE HEALTH<|>COMPANY<|>Cue Health was a company in the Health Care sector from 2014 to 2024, offering at-home diagnostics. They raised $404M but failed due to a post-COVID crash and costs, indicating that planning for cycles is necessary.<|>)\n##\n(\"entity\"<|>DOPAMINE LABS<|>COMPANY<|>Dopamine Labs operated in the Health Care sector from 2015 to 2019, providing behavioral tech for apps. They raised $2.5M but lost focus and faded, showing that focus wins in health.<|>)\n##\n(\"entity\"<|>DOXY.ME<|>COMPANY<|>Doxy.me was a company in the Health Care sector from 2013 to 2018, offering free telemedicine (early). They raised $5M but failed due to an unsustainable free model, indicating that monetization is key.<|>)\n##\n(\"entity\"<|>DRIVER<|>COMPANY<|>Driver operated in the Health Care sector in 2018, providing cancer trial matching. They raised a low amount of funds but failed due to bad pricing and funding, showing that validating willingness to pay is crucial.<|>)\n##\n(\"entity\"<|>DTHERA SCIENCES<|>COMPANY<|>Dthera Sciences was a company in the Health Care sector from 2016 to 2020, offering Alzheimer's therapeutic solutions. They raised $3M but failed due to a small market and funding issues, indicating that niche needs deep pockets.<|>)\n##\n(\"entity\"<|>EARGO<|>COMPANY<|>Eargo operated in the Health Care sector from 2010 to 2023, providing hearing aids. They raised $316M but failed due to fraud allegations and competition, showing that trust is king.<|>)\n##\n(\"entity\"<|>FITSTAR<|>COMPANY<|>FitStar was a company in the Health Care sector from 2013 to 2015, offering a fitness app. They raised $5M but lost steam and were acquired, indicating that a killer edge is needed.<|>)\n##\n(\"entity\"<|>GINGER<|>COMPANY<|>Ginger operated in the Health Care sector from 2011 to 2021, providing mental health support. They raised $220M but failed due to high costs and a merger, showing that profitability matters.<|>)\n##\n(\"entity\"<|>GOLDFINCH BIO<|>COMPANY<|>Goldfinch Bio was a company in the Health Care sector from 2016 to 2023, offering precision kidney meds. They raised $209M but failed due to funding drying up and slow progress, indicating that timing is critical.<|>)\n##\n(\"entity\"<|>HEALX<|>COMPANY<|>Healx operated in the Health Care sector from 2014 to 2023, providing AI for rare diseases. They raised $110M but failed due to a funding crunch and slow results, showing that delivering or downsizing is necessary.<|>)\n##\n(\"entity\"<|>HEALTH IQ<|>COMPANY<|>Health IQ was a company in the Health Care sector from 2014 to 2023, offering health-based insurance. They raised $136M but failed due to risk models and scrutiny, indicating that math and compliance matter.<|>)\n##\n(\"entity\"<|>HEALTHRISER<|>COMPANY<|>HealthRiser operated in the Health Care sector from 2015 to 2019, providing a posture wearable. They raised $8M but lost to Fitbit and costs, showing that mass appeal is needed.<|>)\n##\n(\"entity\"<|>HEALTHSPOT<|>COMPANY<|>HealthSpot was a company in the Health Care sector from 2012 to 2016, offering telemedicine kiosks. They raised $43M but lost to software rivals, indicating that flexibility beats rigidity.<|>)\n##\n(\"entity\"<|>HEALTHTAP+<|>COMPANY<|>HealthTap+ operated in the Health Care sector from 2010 to 2017, providing subscription telemedicine. They raised $88M but failed due to low retention and a pivot, showing that sticky engagement is needed.<|>)\n##\n(\"entity\"<|>HEALTHIFYME<|>COMPANY<|>HealthifyMe was a company in the Health Care sector from 2011 to 2018, offering a fitness app (early). They raised $125M but failed due to slow retention and a pivot, indicating that evolving or losing is necessary.<|>)\n##\n(\"entity\"<|>INTOUCH HEALTH<|>COMPANY<|>InTouch Health operated in the Health Care sector from 2002 to 2020, providing telemedicine robots. They raised $78M but faced scalability issues and were sold, showing that planning for acquisition is crucial.<|>)\n##\n(\"entity\"<|>IRHYTHM<|>COMPANY<|>iRhythm was a company in the Health Care sector from 2006 to 2015, offering a heart monitoring patch. They raised $150M but faced reimbursement woes early, indicating that payer alignment is key.<|>)\n##\n(\"entity\"<|>JAWBONE<|>COMPANY<|>Jawbone operated in the Health Care sector from 2006 to 2017, providing fitness trackers. They raised $930M but failed due to competition and quality issues, showing that differentiating or dying is crucial.<|>)\n##\n(\"entity\"<|>KAIKU HEALTH<|>COMPANY<|>Kaiku Health was a company in the Health Care sector from 2012 to 2020, offering cancer symptom tracking. They raised $6M but faced slow adoption and were acquired, indicating that traction matters.<|>)\n##\n(\"entity\"<|>KYRUUS<|>COMPANY<|>Kyruus operated in the Health Care sector from 2010 to 2015, providing doctor matching (early). They raised $153M but faced a lack of traction and pivoted, showing that validating demand early is crucial.<|>)\n##\n(\"entity\"<|>LANTERN<|>COMPANY<|>Lantern was a company in the Health Care sector from 2012 to 2018, offering digital mental health services. They raised $21M but faced slow adoption and misjudgment, indicating that planning for long cycles is necessary.<|>)\n##\n(\"entity\"<|>LANTERN PHARMA<|>COMPANY<|>Lantern Pharma operated in the Health Care sector from 2013 to 2018, focusing on AI drug repurposing. They raised $26M but faced slow results and pivoted, showing that quick wins matter.<|>)\n##\n(\"entity\"<|>LUMINARY LABS<|>COMPANY<|>Luminary Labs was a company in the Health Care sector from 2017 to 2021, offering AI skincare diagnostics. They raised $12M but faced a crowded market and cash out, indicating that validating the niche early is crucial.<|>)\n##\n(\"entity\"<|>LUMEON<|>COMPANY<|>Lumeon operated in the Health Care sector from 2005 to 2023, providing care orchestration. They raised $92M but faced slow sales and wind-down, showing that budgeting for long runways is necessary.<|>)\n##\n(\"entity\"<|>MEDICHAIN<|>COMPANY<|>MediChain was a company in the Health Care sector from 2017 to 2020, offering blockchain medical records. They raised $15M but lost to Epic and the crypto crash, indicating that real-world buy-in is needed.<|>)\n##\n(\"entity\"<|>MEDICASA<|>COMPANY<|>Medicasafe operated in the Health Care sector from 2012 to 2018, providing a smart pill dispenser. They raised $5M but faced high costs and low uptake, showing that simple beats complex.<|>)\n##\n(\"entity\"<|>MINDSTRONG<|>COMPANY<|>Mindstrong was a company in the Health Care sector from 2014 to 2023, offering mental health via data. They raised $160M but failed due to no actionable insights, indicating that proving outcomes is crucial.<|>)\n##\n(\"entity\"<|>MODERN HEALTH<|>COMPANY<|>Modern Health operated in the Health Care sector from 2017 to 2023, focusing on mental health for employees. They raised $167M but faced layoffs and valuation cuts, showing that growth must match fundamentals.<|>)\n##\n(\"entity\"<|>NURX<|>COMPANY<|>Nurx was a company in the Health Care sector from 2014 to 2019, offering telehealth birth control. They raised $115M but faced regulatory hurdles and competition, indicating that scale and compliance are necessary.<|>)\n##\n(\"entity\"<|>OLIVE<|>COMPANY<|>Olive operated in the Health Care sector from 2012 to 2023, providing AI healthcare automation. They raised $856M but faced a downturn and mismanagement, showing that adapting to shifts is crucial.<|>)\n##\n(\"entity\"<|>OMADA HEALTH<|>COMPANY<|>Omada Health was a company in the Health Care sector from 2011 to 2016, offering diabetes prevention (early). They raised $550M but faced slow payer adoption and pivoted, indicating that payers drive success.<|>)\n##\n(\"entity\"<|>OUTSET MEDICAL<|>COMPANY<|>Outset Medical operated in the Health Care sector from 2010 to 2015, providing portable dialysis (early). They raised $200M but faced production snags and competition, showing that flawless execution is needed.<|>)\n##\n(\"entity\"<|>PEAR THERAPEUTICS<|>COMPANY<|>Pear Therapeutics was a company in the Health Care sector from 2013 to 2023, offering digital therapeutics. They raised $409M but faced reimbursement woes, indicating that therapeutics need economics.<|>)\n##\n(\"entity\"<|>PILLPACK<|>COMPANY<|>PillPack operated in the Health Care sector from 2013 to 2018, providing pre-sorted meds delivery. They", "refusal": null, "role": "assistant", "audio": null, "function_call": null, "tool_calls": null, "annotations": []}}], "created": 1741875877, "model": "gpt-4o-2024-08-06", "object": "chat.completion", "service_tier": "default", "system_fingerprint": "fp_eb9dce56a8", "usage": {"completion_tokens": 4000, "prompt_tokens": 4388, "total_tokens": 8388, "completion_tokens_details": {"accepted_prediction_tokens": 0, "audio_tokens": 0, "reasoning_tokens": 0, "rejected_prediction_tokens": 0}, "prompt_tokens_details": {"audio_tokens": 0, "cached_tokens": 1664}}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [COMPANY,SECTOR]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: COMPANY,SECTOR\nText: | Name                   | Sector                | Years of Operation   | What They Did                     | How Much They Raised     | Why They Failed                         | Takeaway                       |\n|------------------------|-----------------------|----------------------|-----------------------------------|--------------------------|-----------------------------------------|--------------------------------|\n| Vemo                   | Finance and Insurance | 2015-2021            | Income-share agreements           | $20M (est.)              | Lost to Lambda School and regs          | ISAs need traction             |\n| Venmo Groups           | Finance and Insurance | 2015-2020            | Group payments feature            | $0 (Venmo-funded)        | Lost to Splitwise and niche             | Niche payments need use        |\n| Vittana                | Finance and Insurance | 2008-2015            | Student microloans                | $5M (est.)               | Lost to Sofi and low scale              | Microloans need reach          |\n| Wealthfront Cash       | Finance and Insurance | 2018-2023            | High-yield savings                | $0 (Wealthfront-funded)  | Lost to Ally and pivoted                | Savings need edge              |\n| Wealthsimple Trade     | Finance and Insurance | 2017-2023            | Commission-free trading           | $0 (Wealthsimple-funded) | Lost to Robinhood and pivoted           | Trading needs volume           |\n| Wepay                  | Finance and Insurance | 2008-2020            | Payment processing                | $75M                     | Lost to Stripe and sold                 | Payments need scale            |\n| Wesabe                 | Finance and Insurance | 2006-2011            | Personal finance app              | $4M                      | Lost to Mint and early market           | Timing matters                 |\n| Wise                   | Finance and Insurance | 2011-2023            | International transfers           | $689M                    | Lost to PayPal and high costs           | Transfers need edge            |\n| YayPay                 | Finance and Insurance | 2015-2021            | Accounts receivable automation    | $15M                     | Lost to Bill.com and sold               | Automation needs scale         |\n| Ycharts                | Finance and Insurance | 2009-2021            | Financial data platform           | $15M                     | Lost to Bloomberg and sold              | Data needs dominance           |\n| ZestFinance            | Finance and Insurance | 2009-2020            | AI underwriting loans             | $112M                    | Lost to Upstart and regs                | Lending needs compliance       |\n| Aira Health            | Health Care           | 2015-2019            | Personalized asthma/allergy app   | $12M                     | Small user base and cash shortage       | Niche apps need big audiences  |\n| Amino                  | Health Care           | 2013-2021            | Doctor search and cost estimation | $45M                     | Lost to Zocdoc/GoodRx and slow adoption | Narrow focus beats broad       |\n| Arivale                | Health Care           | 2015-2019            | Personalized health coaching      | $50M                     | High costs and low demand               | Premium needs mass market      |\n| Augmedix               | Health Care           | 2012-2024            | Remote medical scribes            | $150M                    | Lost to software rivals and acquired    | Flexibility beats rigidity     |\n| Avizia                 | Health Care           | 2014-2018            | Telemedicine for hospitals        | $32M                     | Outpaced by bigger rivals and acquired  | Niche needs a moat             |\n| Babylon Health         | Health Care           | 2013-2023            | AI-powered telemedicine           | $635M                    | Overexpansion and losses                | Quality must match scale       |\n| Basis                  | Health Care           | 2014-2016            | Health smartwatch                 | $30M                     | Overheating and competition             | Reliability is make-or-break   |\n| Better                 | Health Care           | 2016-2023            | Mental health for employees       | $4.5M                    | Crowded market and no differentiation   | Unique value is critical       |\n| BetterHelp             | Health Care           | 2013-2017            | Online therapy (early)            | $31M                     | Trust issues and competition            | Trust comes first              |\n| BioBeats               | Health Care           | 2014-2020            | Stress monitoring wearable        | $7M                      | Lost to bigger players and acquired     | Standout use case needed       |\n| Call9                  | Health Care           | 2015-2019            | Telemedicine for nursing homes    | $34M                     | Slow growth and high costs              | Execution must scale           |\n| Cardiogram             | Health Care           | 2016-2021            | Heart rate analysis app           | $2M                      | Monetization and differentiation woes   | Validation is key              |\n| CareSync               | Health Care           | 2011-2018            | Care coordination platform        | $48M                     | No payer contracts and revenue          | Need payer buy-in              |\n| CareZone               | Health Care           | 2013-2020            | Medication management app         | $161M                    | Lost to free tools and sold             | Defensible revenue matters     |\n| Clarityn               | Health Care           | 2016-2020            | AI eye diagnostics                | $20M                     | Lost to IDx and regulatory delays       | Regulatory wins are key        |\n| Clinkle                | Health Care           | 2011-2016            | Mobile wallet (health-adjacent)   | $30M                     | Leadership and no product               | Execution over promises        |\n| Cue Health             | Health Care           | 2014-2024            | At-home diagnostics               | $404M                    | Post-COVID crash and costs              | Plan for cycles                |\n| Dopamine Labs          | Health Care           | 2015-2019            | Behavioral tech for apps          | $2.5M                    | Lost focus and faded                    | Focus wins in health           |\n| Doxy.me                | Health Care           | 2013-2018            | Free telemedicine (early)         | $5M                      | Free model unsustainable                | Monetization is key            |\n| Driver                 | Health Care           | 2018-2018            | Cancer trial matching             | $lowM                    | Bad pricing and funding                 | Validate willingness to pay    |\n| Dthera Sciences        | Health Care           | 2016-2020            | Alzheimerâ€™s therapeutic         | $3M                      | Small market and funding                | Niche needs deep pockets       |\n| Eargo                  | Health Care           | 2010-2023            | Hearing aids                      | $316M                    | Fraud allegations and competition       | Trust is king                  |\n| FitStar                | Health Care           | 2013-2015            | Fitness app                       | $5M                      | Lost steam and acquired                 | Killer edge needed             |\n| Ginger                 | Health Care           | 2011-2021            | Mental health support             | $220M                    | High costs and merged                   | Profitability matters          |\n| Goldfinch Bio          | Health Care           | 2016-2023            | Precision kidney meds             | $209M                    | Funding dried up and slow progress      | Timing is critical             |\n| Healx                  | Health Care           | 2014-2023            | AI for rare diseases              | $110M                    | Funding crunch and slow results         | Deliver or downsize            |\n| Health IQ              | Health Care           | 2014-2023            | Health-based insurance            | $136M                    | Risk models and scrutiny                | Math and compliance matter     |\n| HealthRiser            | Health Care           | 2015-2019            | Posture wearable                  | $8M                      | Lost to Fitbit and costs                | Mass appeal needed             |\n| HealthSpot             | Health Care           | 2012-2016            | Telemedicine kiosks               | $43M                     | Lost to software rivals                 | Flexibility beats rigidity     |\n| HealthTap+             | Health Care           | 2010-2017            | Subscription telemedicine         | $88M                     | Low retention and pivot                 | Sticky engagement needed       |\n| HealthifyMe            | Health Care           | 2011-2018            | Fitness app (early)               | $125M                    | Slow retention and pivot                | Evolve or lose                 |\n| InTouch Health         | Health Care           | 2002-2020            | Telemedicine robots               | $78M                     | Scalability issues and sold             | Plan for acquisition           |\n| iRhythm                | Health Care           | 2006-2015            | Heart monitoring patch            | $150M                    | Reimbursement woes early                | Payer alignment is key         |\n| Jawbone                | Health Care           | 2006-2017            | Fitness trackers                  | $930M                    | Competition and quality issues          | Differentiate or die           |\n| Kaiku Health           | Health Care           | 2012-2020            | Cancer symptom tracking           | $6M                      | Slow adoption and acquired              | Traction matters               |\n| Kyruus                 | Health Care           | 2010-2015            | Doctor matching (early)           | $153M                    | Lack of traction and pivot              | Validate demand early          |\n| Lantern                | Health Care           | 2012-2018            | Digital mental health             | $21M                     | Slow adoption and misjudgment           | Plan for long cycles           |\n| Lantern Pharma         | Health Care           | 2013-2018            | AI drug repurposing               | $26M                     | Slow results and pivot                  | Quick wins matter              |\n| Luminary Labs          | Health Care           | 2017-2021            | AI skincare diagnostics           | $12M                     | Crowded market and cash out             | Validate niche early           |\n| Lumeon                 | Health Care           | 2005-2023            | Care orchestration                | $92M                     | Slow sales and wind-down                | Budget for long runways        |\n| MediChain              | Health Care           | 2017-2020            | Blockchain medical records        | $15M                     | Lost to Epic and crypto crash           | Real-world buy-in needed       |\n| Medicasafe             | Health Care           | 2012-2018            | Smart pill dispenser              | $5M                      | High costs and low uptake               | Simple beats complex           |\n| Mindstrong             | Health Care           | 2014-2023            | Mental health via data            | $160M                    | No actionable insights                  | Prove outcomes                 |\n| Modern Health          | Health Care           | 2017-2023            | Mental health for employees       | $167M                    | Layoffs and valuation cuts              | Growth must match fundamentals |\n| Nurx                   | Health Care           | 2014-2019            | Telehealth birth control          | $115M                    | Reg hurdles and competition             | Scale and compliance           |\n| Olive                  | Health Care           | 2012-2023            | AI healthcare automation          | $856M                    | Downturn and mismanagement              | Adapt to shifts                |\n| Omada Health           | Health Care           | 2011-2016            | Diabetes prevention (early)       | $550M                    | Slow payer adoption and pivot           | Payers drive success           |\n| Outset Medical         | Health Care           | 2010-2015            | Portable dialysis (earty)         | $200M                    | Production snags and competition        | Flawless execution needed      |\n| Pear Therapeutics      | Health Care           | 2013-2023            | Digital therapeutics              | $409M                    | Reimbursement woes                      | Therapeutics need economics    |\n| PillPack               | Health Care           | 2013-2018            | Pre-sorted meds delivery          | $118M                    | Profitability woes and sold             | Scale or get gobbled           |\n| Proteus Digital Health | Health Care           | 2004-2020            | Ingestible sensors                | $500M                    | Failed partnership and costs            | Donâ€™t bet on one partner     |\n| Quit Genius            | Health Care           | 2017-2023            | Quit smoking app                  | $77M                     | Low retention and adoption              | Stickiness beyond novelty      |\n\nPageBreak\n######################\nOutput:", "role": "user"}], "parameters": {"model": "gpt-4o", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}}